Join us in wishing the Global Liver Institute a very happy 10th anniversary! We had a great time celebrating the past decade in Milan, and we can’t wait to see what the future may bring.
Amazing!!
Skip to main content
Join us in wishing the Global Liver Institute a very happy 10th anniversary! We had a great time celebrating the past decade in Milan, and we can’t wait to see what the future may bring.
Licensed Clinical and Pediatric Psychologist at Del Sol Therapeutic Services. Board Member of the Liver Coalition of San Diego. Globa Liver Institute Patient Ambassador. PBC advocate.
2moAmazing!!
To view or add a comment, sign in
Looks like the best session is at 15:20 to 15:50
I’m excited to be at The Times Life Sciences Summit here in the wonderful city of Aberdeen today. Looking forward to the keynote speech by my Innovate UK colleague Stella Peace and hearing from all of the other excellent speakers and panelists today. Further information about the event can be found here: https://lnkd.in/eaVeMrqr
To view or add a comment, sign in
Are you planning to work with aged mice and have no idea what to expect? Watch this on-demand webinar to gain insights and acquire knowledge about JAX aged mice. https://lnkd.in/gFJZSnHb #agedmice #research #aged #preclinical #micemodel
To view or add a comment, sign in
Early investigators of antisense oligos will remember this seminal paper by the Walders and appreciate its impact: Role of RNase H in hybrid-arrested translation by antisense oligonucleotides ROXANNE Y. WALDER and JOSEPH A. WALDER* Department of Biochemistry, University of Iowa Proc. Nati. Acad. Sci. USA Vol. 85, pp. 5011-5015, July 1988 https://lnkd.in/e4Tnz2PB Last paragraph: “For antisense oligodeoxynucleotides to be used to block the expression of selected genes within intact cells, it may be necessary to modify the oligonucleotide to decrease its rate of degradation and improve intracellular transport. An important corollary of our results is that such modified analogs must not only retain normal hybridization properties but should also form substrates that are recognized and cleaved by RNase H.”
It’s with great sadness that we share the passing of Dr. Joseph Walder–the remarkable man who founded IDT, and whose work has made a profound impact on the scientific community. In 1987, when Dr. Walder established IDT as a joint venture with Baxter Healthcare, his premise for IDT was simple: make science accessible to move discoveries forward. More than 35 years later, his vision has grown into a high-growth, high-impact business with a global footprint that now enables researchers worldwide to accelerate the pace of genomics. We celebrate the life of Dr. Walder and all the incredible things he has built from his one small idea in 1987, and his beautiful legacy of supporting science innovation, sustainability, and the community. 🕊
To view or add a comment, sign in
Tomorrow marks the 4th of July, a day to celebrate America's independence and the innovative spirit that has fueled our nation. Here at BioHub Maryland, we're proud to carry that torch forward by fostering collaboration and accelerating talent in the life sciences industry. Celebrate with us by answering one of these questions in the comments below: • What scientific discovery are you most grateful for? • How do you see science shaping the future of America?
To view or add a comment, sign in
We asked some of our brilliant minds at Medicon Village how they spend their summer holidays and about their professional focus for the second half of 2024. This is how Jonas Söderström at BioStock answered: "Summers are spent with my family and we always try to squeeze in a trip to Italy 🇮🇹, preferably driving down (by EV of course) so we can explore spontaneously along the way. As someone said: ”the journey is the goal, not the actual destination” – or something like that. And when mentioning goals: being in Milan surrounded by crazy football fans when Italy scored that last-second goal to stay in the Euro Cup was one spectacular memory we got, this time around! At BioStock we have our sights set on providing our clients and Swedish life science with even more visibility and value, by constantly developing new services, build our media platform and expand our popular events. With the successful premiere of the Global Forum event in May behind us, we’re looking forward to the BioStock Summit i November with several new features (cliffhanger!), but before that we’ll also have an investor focused event in Stockholm in September… it’s gonna be great. But first we’ll enjoy some more summer laziness!" #brilliantminds #lifescience #sciencepark BioStock - Connecting Innovation and Capital
To view or add a comment, sign in
Topics for discussion are online. Come to discuss with Sanofi UCB Roche Syensqo Galapagos Zifo Bayer BASF GSK and others! Click below to register I look forward to seeing you there! #ScientificInformatics #Research #Development #ScientificDataManagement #LabDataAutomation
Excited to announce the Topics for our 2024 Scientific Informatics Experience Exchange in Basel, Switzerland. Join us on April 9 at the Mövenpick Hotel Basel Click to Register: https://lnkd.in/gm-Ka4gJ
To view or add a comment, sign in
Rosalie Lipsh-Sokolik, congratulations! This is extremely well deserved for the fantastic work you did as a Ph.D.! I'm so happy to see this :) Briefly, Rosalie developed new methods for designing libraries of highly functional proteins. In the process, we learned new lessons on the importance of preorganisation, stability, and, most importantly, how to introduce many function-enhancing mutations in an active site without killing the protein. Rosalie then showed how to design huge libraries for experimental screening and isolated more than 10,000 efficient and sophisticated enzymes in one screen each encoding more than 100 mutations from any natural enzyme -- numbers that we never saw before. I certainly didn't think that protein activity could be designed on such a huge scale. There are already many areas of enzyme and binder engineering that are benefiting from Rosalie's great work, and this is just the start! Good luck with your postdoc, Rosalie!
🏆 The laureates of the Birnstiel Award 2023 have been selected! 🏆 With 103 nominations from across the globe, the award is an established accolade – one of the most competitive awards of its kind. Congrats to our 6 awardees and 7 honourable mentions! Read about their research here 👉🏼 https://lnkd.in/d4UHJjtJ 👈🏼 Our brilliant awardees: Sam van Beljouw, supervised by Stan Brouns of Delft University of Technology. Ana Paredes, Ph.D., supervised by Mercedes Ricote at CNIC - Spanish National Center for Cardiovascular Research / Centro Nac. Investigaciones Cardiovasc. Ariën Schiepers, supervised by Gabriel D. Victora at The Rockefeller University. Ida Marie Astad Jentoft, supervised by Melina Schuh at the Max Planck Institute for Multidisciplinary Sciences. Rosalie Lipsh-Sokolik, supervised by Sarel Fleishman at Weizmann Institute of Science. Stanislau Yatskevich, supervised by David Barford at MRC Laboratory of Molecular Biology (LMB). We look forward to welcoming them all at the Vienna BioCenter for the award ceremony in November.
To view or add a comment, sign in
🔬Exciting Update!🔬 Our team's research on SGLT2 inhibitors' effects on Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) in lipodystrophic mice is now published! Kudos to the team for this collaborative effort! 🤝🔬 Perrine Déniel Xavier Prieur Cédric Le May #MASLD #SGLT2i #Empagliflozin #Lipodystrophy
Happy to share this collaborative work with Cédric Le May on the benefit of empagliflozin on MASLD in a mice model of lipodystrophy. Congrats to Thibaud SOTIN and Sarra Smati for the nice work! https://lnkd.in/eEjm8RBp
To view or add a comment, sign in
It's always exciting to chat about upcoming projects, share insights, and explore how we can support each other within the Ann Arbor bioscience space. Look for Wendy Wise and I with our Innovative Research badges. Let’s make this event memorable! 🚀 #ScienceCommunity #CollaborationMatters #AnnArborResearch
Join us for the special End of Season Celebration at Circ Bar next week on June 4th. We are targeting over 200 attendees for this special event to celebrate the growth of our community and ecosystem over the past 10 months. We recently passed the 900 member mark and hope to be at 1,000 soon! Come see your fellow life science enthusiasts! https://lnkd.in/gpY6Akbg
To view or add a comment, sign in
Professor in Molecular Biology, Bulgarian Academy of Sciences; Co-founder & Chief Science Officer EPIX.AI; Science communicator
🚀 Exciting News! 🌟 I'm thrilled to announce that EPIX.AI has taken a significant step forward in our mission to impact society positively. We are proud to be part of SpinOff Bulgaria, an initiative supporting innovative ventures and fostering entrepreneurship. Thank you, Kristina Eskenazi and your excellent team, for having us there! At EPIX.AI, we're not just about cutting-edge technology. We're also passionate about advancing research in ageing and age-related diseases. Our commitment to this cause runs deep, and we firmly believe that by harnessing the power of #AI and #data, we can contribute to groundbreaking discoveries that will improve the quality of life for generations to come. Join us to explore the uncharted territories of healthcare and age-related research. Together, we can redefine what's possible and make a difference that truly matters. 🔗 Learn more about our work and the importance of ageing research: https://www.epix.ai/ Andrey Bachvarov, Ph.D Dr. Solomon Passy Nikolay V. Ivan Tsenov Matyo Ivanov Momchil Topalov #EPIXAI #SpinoffBulgaria #AgeingResearch #Innovation #Entrepreneurship #MakeADifference 🌍💪
Last Thursday, Epix.AI was awarded the title of best Bulgarian Spinoff Company in 2023! We had the pleasure of being included in the Bulgarian Health and Sciences Cluster, headed by the amazing Kristina Eskenazi. We would like to thank her for this notable distinction and for organizing an amazing event, attended by Federico Menna, CEO of EIT Digital, Marina Zanchi, Director of the European Health and Digital Executive Agency (HaDEA) and Nikolai Denkov Prime minister of Bulgaria
To view or add a comment, sign in
Create your free account or sign in to continue your search
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Thank you for your support and for celebrating 10 years of Impact with us. #GlobalLiverDecade We look forward to continuing to serve patients.